The current results show that number needed to benefit (NNTB) was 207 (95%CI: NNTB 129 to NNTB 620, Follow-up time: 3.48 1.51 years) for total MI, NNTB 67 (95%CI: NNTB 46 to NNTB 135, Follow-up time: 3.48 1.51 years) for MACE, NNTB 170 (95%CI: NNTB 120 to NNTB 306, Follow-up time: 3.48 1.51 years) for cardiovascular mortality, and NNTB 93 (95%CI: NNTB 52 to NNTB 1717, Follow-up time: 3.45 1.21 years) for coronary revascularization
Topical glutathione shows some promise, particularly at 2% concentration, but penetration and stability are challenges
Confirm the evidence stage
Parmi les plus riches, on retrouve les lgumes crucifres comme le brocoli, les choux et les asperges, qui contiennent la fois du glutathion et des composs soufrs stimulant sa synthse
Our review provides insights into the interplay of lifestyle factors, genetic predispositions, and the significant psychological and physiological burdens associated with managing these comorbid conditions
Saxenda (liraglutide) is a GLP-1 receptor agonist licensed for weight management, not menstrual regulation Menstrual changes during treatment result from weight loss effects on hormones rather than direct drug action Weight reduction improves insulin sensitivity and reduces excess oestrogen from adipose tissue Women with obesity-related menstrual irregularities or PCOS may see improved cycle regularity with weight loss Consult your GP if you experience missed periods, heavy bleeding, or persistent irregularities during treatment Table of Contents Does Saxenda Regulate Period